Malignant mesothelioma, otherwise known as mesothelioma cancer, commonly
develops in the lungs of people exposed to asbestos. Effective
treatments are available to ease symptoms and improve your prognosis.
The cancer usually affects the thin, protective membrane surrounding
the lungs, heart or abdominal cavity. Doctors diagnose an estimated
3,000 cases a year in the United States, and the majority of those are
traced to job-related asbestos exposure.
Although asbestos use declined dramatically in recent decades in this
country, the incidence of malignant mesothelioma remains steady. That
difference can be traced to the distinct latency period linked to the
cancer. The disease can take anywhere from 20 to 50 years after exposure
to asbestos before it shows obvious symptoms and an oncologist can make
a definitive diagnosis. While no cure for the disease exists and the
prognosis is typically poor, researchers made significant progress in
recent years in understanding the cancer and developing new treatment
options and alternative therapies.


